Marrow graft rejection and veno-occlusive disease of the liver in patients with aplastic anemia conditioned with cyclophosphamide and cyclosporine

H. Joachim Deeg, Howard M. Shulman, Elizabeth Schmidt, Gary C Yee, E. Donnall Thomas, Rainer Storb

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Based on studies in multiply transfused dogs showing that cyclosporine (CsA) pregrafting reduced the incidence of rejection, we treated 11 multiply transfused patients with severe aplastic anemia with CsA, 12.5–20 mg/kg/day i.m. on days-6 to-1, and cyclophosphamide, 50 mg/kg/day i.v. on days −5 to −2, followed on day 0 by a marrow graft from an HLA-identical sibling donor. Patients were not given additional infusions of buffy coat cells from their marrow donors. As postgrafting prophylaxia for graft-versus-host disease 10 patients were give CsA, 12.5 mg/kg/day orally, and one patient was given a standard regimen of intermittent method

Original languageEnglish (US)
Pages (from-to)497-501
Number of pages5
JournalTransplantation
Volume42
Issue number5
DOIs
StatePublished - Jan 1 1986

Fingerprint

Aplastic Anemia
Graft Rejection
Cyclophosphamide
Cyclosporine
Liver Diseases
Bone Marrow
Tissue Donors
Glycocalyx
Graft vs Host Disease
Siblings
Dogs
Transplants
Incidence

ASJC Scopus subject areas

  • Transplantation

Cite this

Marrow graft rejection and veno-occlusive disease of the liver in patients with aplastic anemia conditioned with cyclophosphamide and cyclosporine. / Deeg, H. Joachim; Shulman, Howard M.; Schmidt, Elizabeth; Yee, Gary C; Thomas, E. Donnall; Storb, Rainer.

In: Transplantation, Vol. 42, No. 5, 01.01.1986, p. 497-501.

Research output: Contribution to journalArticle

Deeg, H. Joachim ; Shulman, Howard M. ; Schmidt, Elizabeth ; Yee, Gary C ; Thomas, E. Donnall ; Storb, Rainer. / Marrow graft rejection and veno-occlusive disease of the liver in patients with aplastic anemia conditioned with cyclophosphamide and cyclosporine. In: Transplantation. 1986 ; Vol. 42, No. 5. pp. 497-501.
@article{7b430f7cf26949d1b9fba4a73d00fc9f,
title = "Marrow graft rejection and veno-occlusive disease of the liver in patients with aplastic anemia conditioned with cyclophosphamide and cyclosporine",
abstract = "Based on studies in multiply transfused dogs showing that cyclosporine (CsA) pregrafting reduced the incidence of rejection, we treated 11 multiply transfused patients with severe aplastic anemia with CsA, 12.5–20 mg/kg/day i.m. on days-6 to-1, and cyclophosphamide, 50 mg/kg/day i.v. on days −5 to −2, followed on day 0 by a marrow graft from an HLA-identical sibling donor. Patients were not given additional infusions of buffy coat cells from their marrow donors. As postgrafting prophylaxia for graft-versus-host disease 10 patients were give CsA, 12.5 mg/kg/day orally, and one patient was given a standard regimen of intermittent method",
author = "Deeg, {H. Joachim} and Shulman, {Howard M.} and Elizabeth Schmidt and Yee, {Gary C} and Thomas, {E. Donnall} and Rainer Storb",
year = "1986",
month = "1",
day = "1",
doi = "10.1097/00007890-198611000-00011",
language = "English (US)",
volume = "42",
pages = "497--501",
journal = "Transplantation",
issn = "0041-1337",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Marrow graft rejection and veno-occlusive disease of the liver in patients with aplastic anemia conditioned with cyclophosphamide and cyclosporine

AU - Deeg, H. Joachim

AU - Shulman, Howard M.

AU - Schmidt, Elizabeth

AU - Yee, Gary C

AU - Thomas, E. Donnall

AU - Storb, Rainer

PY - 1986/1/1

Y1 - 1986/1/1

N2 - Based on studies in multiply transfused dogs showing that cyclosporine (CsA) pregrafting reduced the incidence of rejection, we treated 11 multiply transfused patients with severe aplastic anemia with CsA, 12.5–20 mg/kg/day i.m. on days-6 to-1, and cyclophosphamide, 50 mg/kg/day i.v. on days −5 to −2, followed on day 0 by a marrow graft from an HLA-identical sibling donor. Patients were not given additional infusions of buffy coat cells from their marrow donors. As postgrafting prophylaxia for graft-versus-host disease 10 patients were give CsA, 12.5 mg/kg/day orally, and one patient was given a standard regimen of intermittent method

AB - Based on studies in multiply transfused dogs showing that cyclosporine (CsA) pregrafting reduced the incidence of rejection, we treated 11 multiply transfused patients with severe aplastic anemia with CsA, 12.5–20 mg/kg/day i.m. on days-6 to-1, and cyclophosphamide, 50 mg/kg/day i.v. on days −5 to −2, followed on day 0 by a marrow graft from an HLA-identical sibling donor. Patients were not given additional infusions of buffy coat cells from their marrow donors. As postgrafting prophylaxia for graft-versus-host disease 10 patients were give CsA, 12.5 mg/kg/day orally, and one patient was given a standard regimen of intermittent method

UR - http://www.scopus.com/inward/record.url?scp=0023002569&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023002569&partnerID=8YFLogxK

U2 - 10.1097/00007890-198611000-00011

DO - 10.1097/00007890-198611000-00011

M3 - Article

VL - 42

SP - 497

EP - 501

JO - Transplantation

JF - Transplantation

SN - 0041-1337

IS - 5

ER -